Alisertib is a potent and selective inhibitor of Aurora kinase A (AURKA), an enzyme that plays a crucial role in cell mitosis. By inhibiting AURKA, alisertib disrupts the proper division of cancer cells, leading to cell cycle arrest and apoptosis. This makes it a promising therapeutic agent in cancer treatment.